SERAGEN, INC., A CORPORATION OF DELAWARE

Organization

HOPKINTON, MA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method of using cell surface receptor targeted molecules for the tr...
- Patent number 6,074,636
- Issue date Jun 13, 2000
- Seragen, Inc.
- Jean C. Nichols
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hybrid molecules having translocation region and cell-binding region
- Patent number 6,022,950
- Issue date Feb 8, 2000
- Seragen, Inc.
- John R. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant DNAS encoding three-part hybrid proteins
- Patent number 5,965,406
- Issue date Oct 12, 1999
- Seragen, Inc.
- John R. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Epidermal growth factor receptor targeted molecules for treatment o...
- Patent number 5,906,820
- Issue date May 25, 1999
- Seragen, Inc.
- Patricia A. Bacha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mammalian model of a malignant disorder
- Patent number 5,684,221
- Issue date Nov 4, 1997
- Seragen, Inc.
- Serene E. Forte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hybrid molecules having translocation region and cell-binding region
- Patent number 5,668,255
- Issue date Sep 16, 1997
- Seragen, Inc.
- John R. Murphy
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Epidermal growth factor receptor targeted molecules for treatment o...
- Patent number 5,614,488
- Issue date Mar 25, 1997
- Seragen, Inc.
- Patricia A. Bacha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating diabetes
- Patent number 5,571,507
- Issue date Nov 5, 1996
- Seragen, Inc.
- Vicki E. Rubin-Kelley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Purification of Il-2-containing hybrid compounds
- Patent number 5,110,912
- Issue date May 5, 1992
- Seragen, Inc.
- Leonard F. Estis
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Trademarklast 30 trademarks

Information Trademark
74002162 - SERAGEN
- Serial number 74002162
- Filing date Nov 16, 1989
- SERAGEN, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
74002263 - SERAGEN
- Serial number 74002263
- Registration number 1705739
- Filing date Nov 16, 1989
- SERAGEN, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
74002273 - SERAGEN
- Serial number 74002273
- Registration number 1705740
- Filing date Nov 16, 1989
- SERAGEN, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
73368470 - CELL-ECT
- Serial number 73368470
- Filing date Jun 7, 1982
- Seragen, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
73353125 - SERAGEN
- Serial number 73353125
- Registration number 1250769
- Filing date Mar 5, 1982
- Seragen, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
73353124 - SERAGEN
- Serial number 73353124
- Registration number 1250768
- Filing date Mar 5, 1982
- Seragen, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
73353123 - SERAGEN
- Serial number 73353123
- Registration number 1250767
- Filing date Mar 5, 1982
- Seragen, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

SERAGEN, INC., A CORPORATION OF DELAWARE

Organization

Patents Grantslast 30 patents

Method of using cell surface receptor targeted molecules for the tr...

Hybrid molecules having translocation region and cell-binding region

Recombinant DNAS encoding three-part hybrid proteins

Epidermal growth factor receptor targeted molecules for treatment o...

Mammalian model of a malignant disorder

Hybrid molecules having translocation region and cell-binding region

Epidermal growth factor receptor targeted molecules for treatment o...

Methods of treating diabetes

Purification of Il-2-containing hybrid compounds

Patents Applicationslast 30 patents

Trademarklast 30 trademarks

74002162 - SERAGEN

74002263 - SERAGEN

74002273 - SERAGEN

73368470 - CELL-ECT

73353125 - SERAGEN

73353124 - SERAGEN

73353123 - SERAGEN